FIGURE 1.

Overall survival of whole cohort (A), according to underlying disease (B), according to previous administration of anti‐CD20 monoclonal antibody (C), and according to COVID‐19 severity at the time of CCP infusion (D). AID, autoimmune disease; HM, hematological malignancy; SOT, solid organ transplant recipient. WHO scale 5: hospitalized, oxygen by mask or nasal prongs; WHO scale 6: hospitalized, oxygen by noninvasive ventilation or high flow. Survival curves were plotted with the Kaplan–Meier method. Overall survival was estimated after a log rank test. p < 0.05 was considered significant.